Shaanxi Micot Pharmaceutical Technology Co., Ltd. (HKG:2335)

Market Cap	7.67B
Revenue (ttm)	n/a
Net Income	-420.73M
EPS	-1.64
Shares Out	331.74M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,993,200
Open	24.40
Previous Close	24.42
Day's Range	23.08 - 25.94
52-Week Range	10.80 - 45.04
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About HKG:2335

Shaanxi Micot Pharmaceutical Technology Co., Ltd. engages in discovery, development and commercialization of bi-/multi-specific peptide drugs. The company engages in discovery, development and commercialization of bi-/multi-specific peptide drugs for the treatment of metabolic diseases as well as for cancer, cardiovascular, cerebrovascular, and neurological systemic diseases. The company was founded in founded in 2007 and is headquartered in Xi'an, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 153
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2335

Financial Performance

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 10, 2026

Data Sources Report a data error